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Major myelin proteolipid (MMPL, aiso called PLP) and DM-20 are the two major intrinsic membrane pro- 
teins of CNS myelin. A specific immunological probe was obtained for MMPL by raising antibodies against 
the synthetic tridecapeptide 117-129 of MMPL. Antibodies against this peptide reacted with the MMPL 
but dit not cross react with DM-20, while both proteolipids had been shown previously to be recognized 
by antibodies directed against the C-terminal hexapeptide of MMPL. This is in accordance with previous 
findings showing that DM-20 differs only from MMPL by a deletion of residues 100-140 (+ few units). 
Furthermore, this site-specific immunological probe also recognizes MMPL in its native form in oligoden- 
drocytes in primary glial cell cultures. 
Site spec~fieity Synthetic peptide Myelin Proteolipid Oligodendrocyte Membrane protein 
1. INTRODUCTION 
Central nervous system myelin contains several 
intrinsic membrane proteins. The two major ones 
are known to be the major myelin proteolipid 
(~~PL) and DM-20. The primary structure of 
bovine brain MMPL has been established by Lees’ 
and Stoffel’s groups [1,2]. Recently a cDNA clone 
coding for rat brain MMPL was isolated and com- 
parison of the encoded sequence with bovine 
MMPL showed a complete homology except for 4 
amino acid residues 131; on the other hand total se- 
quence homology was described for the human 
MMPL [4]. 
The amino acid sequence of DM-20 has not been 
completely elucidated, but it has been shown to 
have a high degree of structural similarity with the 
MMPL 15-71 and recently Trifilieff et al. [S] 
reported that bovine DM-20 only differs from 
bovine MMPL by a deletion of residues 100-140 
(25 few units). 
According to the primary sequence of the 
MMPL, two models of its integration in the myelin 
membrane have been proposed but with a signifi- 
cant difference: in Lees’ model [9], the main 
hydrophilic loop (residues 90-151) is oriented 
towards the cytoplasmic space, while in Stoffel’s 
model [lo] it is oriented towards the extracytosolic 
side. Immunocytochemical investigations with 
specific antibodies directed against his hydrophilic 
loop could be of help for defining the orientation 
of the MMPL in the myelin. Furthermore a 
specific immunological probe for the MMPL that 
does not cross react with DM-20 can be obtained 
if antibodies are directed against a polypeptide se- 
quence included in the deletion. 
As it is known that antibodies against a peptide 
can react with the corresponding amino acid se- 
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quence in the intact protein [l I], we synthesized a (1 h, O’C). The crude peptide was purified by gel 
peptide which comprises residues 117-129 of the filtration on Biogel F-2 in 0.1 M acetic acid fol- 
MMPL. Antibodies directed against this peptide lowed by ion-exchange chromatography on CM-52 
indeed reacted with the MMPL after electro- (Whatman) with a conductivity gradient in am- 
immunobiotting but not at all with the DM-20, monium acetate buffer. The peptide eluted at 
while both proteolipids were recognized by anti- 18 mS at room temperature. Its homogeneity was 
bodies directed against the C-terminal hexapeptide checked by HPLC and amino acid analysis after 
of the MMPL [7]. We also showed that this hydrolysis in 6 N HCl at I 10°C for 24 h (uncor- 
specific serum labels the MMPL in its native form rected values: Thr 0.8, Ser 0.7, GIu I .8, Gly 5.0, 
in oligodendroc~es in primary glial cell cultures. His 1.1, Lys 1 .O, Arg 2.1). 
2. MATERIALS AND METHODS 
This peptide (10 mg) was coupled to KLH 
(60 mg) in the presence of glutaraldehyde for 
90 min as described in [20]. 
2.1. Materials 
Keyhole limpet hemocyanin (KLH) was ob- 
tained from Calbiochem Behring Corp.; sheep 
(anti-rabbit IgG) antibodies conjugated to 
horseradish peroxidase and FITC-labeled sheep 
(anti-rabbit IgCi) antibodies were from Biosys 
(Compiegne, France); nitrocelluiose paper 
(0.45 pm pore size) was from Millipore. All other 
reagents were obtained from the usual commercial 
sources at the highest available degree of purity. 
2.3. Imm~~izat~on 
Total bovine brain proteolipids and pure bovine 
MMPL were obtained as described in [12]. Pure 
bovine DM-20 was purified as described in [12] or 
1131. Myelin and total rat brain proteolipids were 
obtained from adult Wistar rats as reported [14, 
151. 
Two rabbits were injected subcutaneously on 
days 0,20 and 48 with 300 ~1 of a solution contain- 
ing 1 mg of synthetic peptide 117-129 coupled to 
KLH and 300 @I of either Freund’s complete adju- 
vant (day 0) or incomplete adjuvant (days 20 and 
48). The rabbits were bled on day 64 and the serum 
was kept frozen at - 20°C. The antisera were used 
without removal of KLH carrier antibodies. 
2.4. Po~yacry~amide g / e~ect~ophoresis 
2.2. Synthesis of the tridecapeptide I1 7-129 of 
Synthesis of the tridecapeptide H-Thr-Gly-Gly- 
Gln-Lys-Gly-Arg-Gly-Ser-Arg-Gly-Gln-His-OH 
was performed by the solid-phase method of Mer- 
rifield [ 161 on aminobenzyl resin [ 17,181 with a 
substitution of 1 mmol NHz/g. The Boc-amino 
acids were coupled with dicyclohexylcarbodiimide 
(DCCD) in methylene chloride in 2.5 excess over 
the free amines, except glutamine which was coup- 
led by DCCD and I-hydrozybenzotriazole in di- 
methylformamide [19]. The side chain protections 
were benzyl ether for threonine and serine, ben- 
zyloxycarbonyl for lysine, tosyl for arginine and 
histidine. The lysine and histidine derivatives were 
purchased as their dicyclohexylamine salts and 
neutralized just before the coupling step. After 
total assembly of the peptide on the resin, cleavage 
and simultaneous deprotection of the side chains 
were achieved by anhydrous hydrogen fluoride 
Electrophoresis was performed according to the 
method of Laemmli [21] consisting of a linear gra- 
dient of acrylamide (lo-20%) containing 0.1 @lo 
SDS. The stacking gel was made up of 4% acryl- 
amide. A constant voltage of 110 V was applied 
for 7 h, 
2.5. Immunoblotting 
Proteins were electrophoretically transferred 
from slab gel to nitrocellulose sheets according to 
the method of Towbin et al. 1221. NitrocelIuiose 
sheets containing sample proteins were incubated 
overnight in PBS containing 3% (w/v) BSA and 
2.5% (v/v) normal sheep serum (buffer A). Rabbit 
sera were added at a concentration of l/2000 and 
incubation was conducted for 2 h at room 
temperature. The nitrocellulose sheets were rinsed 
several times with PBS and afterwards incubated 
in buffer A containing sheep (anti-rabbit IgG) an- 
tibodies conjugated to horseradish peroxidase 
(l/1000 diluted). After an additional washing step, 
the antibody binding was detected with 4-chloro- 
I -naphthol and hydrogen peroxide f23f. 
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Fig. 1. Electroimmunoblot analysis of pure MMPL (A), pure DM-20 (B), total bovine brain proteolipids (C), total rat 
brain proteolipids (D) and rat brain myelin proteins (E) with the anti-tridecapeptide 117-129 and the anti-C-terminal 
hexapeptide antisera. Approximative protein amounts (estimated by the Lowry method [27]) applied onto the gel: (A) 
20, (B) 20, (C) 20, (D) 95, (E) 40,~g. Lanes: 1, 4, 7, 10 and 13, gel strips stained after electrophoretic transfer; 2, 5, 
8, 11 and 14, nitrocellulose strips after visualization of the peroxidase activity following incubation with the anti- 
tridecapeptide antiserum; 3,6,9, 12 and 15, nitrocellulose strips after visualization of the peroxidase activity following 
incubation with the anti-C-terminal hexapeptide antiserum. 
2.6. Cell culture and immunofluorescence 
procedures 
Primary glial cell cultures enriched in oligoden- 
drocytes were prepared and maintained as reported 
earlier [24]. Immunofluorescence experiments 
were performed either on fixed or live cell cultures 
following respectively methods A and B described 
in [25] using appropriate dilutions of the anti- 
tridecapeptide antiserum and FITC labeled sheep 
(anti-rabbit IgG) antibodies. 
3. RESULTS AND DISCUSSION 
The tridecapeptide 117-129 of the MMPL, H- 
Thr-Gly-Gly-Gln-Lys-Gly-Arg-Gly-Ser-Arg-Gly- 
Gln-His-OH was synthesized, coupled to KLH and 
used to immunize rabbits. 48 days after the first in- 
oculation, anti-tridecapeptide antibodies were 
detected by the dot-immunobinding assay [23]. 
The specificity of the anti-tridecapeptide anti- 
bodies was checked by electroimmunoblotting ex- 
periments. Pure MMPL (fig.lA) and pure DM-20 
(fig. 1B) were examined first; after immunoreac- 
tion, only pure MMPL could be detected (fig.lA, 
lane 2); no antibody binding occurred with pure 
DM-20 (fig.lB, lane 5). 
The specificity of this antiserum for MMPL was 
further confirmed by electroimmunoblotting of 
total bovine brain proteolipids, total rat brain pro- 
teolipids and rat brain myelin proteins (fig. lC-E). 
In the 3 samples, only one strongly stained band 
was detected at the level of the MMPL band. Con- 
firmation of this specificity was also given by com- 
parison of these results with electroimmunoblots 
of the same samples obtained with the anti C- 
terminal hexapeptide of the MMPL antiserum 
prepared by Nussbaum et al. [7]: pure MMPL 
(fig.lA, lane 3) and pure DM-20 (fig.lB, lane 6) 
were positive after immunoreaction as well as in 
the different samples of total bovine brain proteo- 
lipids (fig.lC, lane 9), total rat brain proteolipids 
(fig.lD, lane 12) and rat brain myelin proteins 
(fig.lE, lane 15). Additional immunoreactive 
bands are also visible on the different immuno- 
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Fig.2. ImmunofIuorescence (a,c) and respective phase-contrast (b,d) micrographs of live (a,bf and fixed (c,d) primary 
glial cell cultures from newborn rat brain hemispheres (17 days after plating) incubated with the anti-tridecapeptide an- 
tiserum. No immunolabeling was observed on live cells; cells identified as oligodendrocytes, lying on the top of a con- 
. tinuous layer of astrocytes, are positively stain’ed only after preliminary permeabilization. x 280. 
blots; high molecular mass bands are due to 
MMPL and DM-20 aggregates; the presence of a 
stained band of - 16 kDa (fig. IC, lane 9) is in ac- 
cordance with the existence in bovine brain of 
small minor proteolipids [ 121 structurally related 
to the MMPL (to be published). 
These experiments how unambiguously that the 
anti-tridecapeptide antiserum reacts with the 
MMPL but does not cross react with DM-20; this 
antiserum therefore constitutes a specific immuno- 
logical probe for the MMPL. These results are in 
good agreement with our previous work on pure 
DM-20 and confirm that DM-20 differs from the 
MMPL by a single deletion of residues 1 OO- 140 ( +- 
few units) [8]. 
This specific immunological probe directed 
against residues 117-129 of the main hydrophilic 
loop of the MMPL might be very useful in studies 
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concerning the synthesis, transport and incorpora- 
tion of this proteolipid in the myelin membrane. 
We therefore started immunofluorescence studies 
on primary glial cell cultures enriched in oligoden- 
drocytes, cells which are responsible for the syn- 
thesis of CNS myelin [26]. Since no immunolabel- 
ing was observed on live cells (fig.2a,b), we con- 
cluded that the hydrophilic loop of the MMPL is 
not accessible, under our experimental conditions, 
at the surface of the oligodendrocytes. Labeling 
was then performed on identical cell cultures after 
preliminary permeabilization of the cells with 
ethanol/PBS (95/5, v/v) and acetone at -70°C 
[25]; fig.ac,d shows that the oligodendrocytes lying 
on the top of the astrocyte layer are highly labeled, 
particularly at their periphery; staining is also 
observed along their processes. This immuno- 
fluorescence pattern is similar to that obtained 
with the anti C-terminal hexapeptide antiserum 
[24], and therefore confirms that the anti-trideca- 
peptide antiserum recognizes the MMPL in its 
native form. 
Immunocytochemical studies on myelin mem- 
brane with the present specific immunological pro- 
be will enable a greater refinement of MMPL 
localization in myelin. In addition, it is now possi- 
ble, using double immunolabeling experiments, to 
study comparatively the synthesis, transport and 
incorporation of both MMPL and DM-20 in the 
myelin membrane. 
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